BioCryst Pharmaceuticals
BCRX
#5073
Rank
โ‚น143.56 B
Marketcap
โ‚น681.86
Share price
-3.07%
Change (1 day)
2.70%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2025 (TTM): -โ‚น4.11

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น4.49. In 2024 the company made an earnings per share (EPS) of -โ‚น38.63 an increase over its 2023 EPS that were of -โ‚น106.01.

EPS history for BioCryst Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.11-89.37%
2024-โ‚น38.63-63.56%
2023-โ‚น106.01-11.28%
2022-โ‚น119.4829.13%
2021-โ‚น92.53-4.63%
2020-โ‚น97.0210.2%
2019-โ‚น88.040%
2018-โ‚น88.0425.64%
2017-โ‚น70.074%
2016-โ‚น67.3827.12%
2015-โ‚น53.00-13.24%
2014-โ‚น61.0923.64%
2013-โ‚น49.41-30.38%
2012-โ‚น70.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Repligen
RGEN
โ‚น2.70-160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น246.15 5,380.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น60.19 1,240.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น190.45-4,340.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น585.73-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น303.65 6,660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น323.05-7,291.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
โ‚น126.67-2,920.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,010 22,380.00%๐Ÿ‡บ๐Ÿ‡ธ USA